Regulatory & Legal

With a new $100M investment, Ontario expands its fertility program, aiming to slash wait times and make parenthood more accessible across the province.

A new ultra-short-acting drug for cardiac emergencies is now in US hospitals, offering doctors faster control and broader use across all age groups.

A landmark study shows a novel device can safely treat severe artery blockages below the ankle, offering new hope for patients at risk of amputation.

Amid rising demand for flexible stays, Landing hires key leaders in finance and partnerships to accelerate its national expansion and solidify its market position.

Amid a global energy crisis, Greenland Energy's 13-billion-barrel Arctic gamble gains momentum, but faces immense environmental and financial risks.

A new partnership links Wiz's cloud risk detection directly to C1's identity engine, promising real-time, automated access decisions for the AI era.

Roman DBDR adds board heavyweight Randolph C. Read as it prepares to merge with ThomasLloyd, signaling a focus on steering the $850M+ climate deal.

As GPS jamming becomes a critical threat, Northrop Grumman's new EGI-M system, powered by Green Hills software, ensures US jets stay on target.

A startup's novel 4D mammography system completes its first human trial, promising to detect cancer's molecular fingerprint and slash false positives.

Tom's Watch Bar partners with Sports Illustrated Tickets to let fans book their exact seats for big games, ending the game-day scramble for good.

With Q3 results and a leadership tour imminent, the luxury giant's performance will be a key barometer for a sector facing economic and competitive shifts.

A new HHS agenda reopens the door for controversial peptides, just as a wave of next-gen obesity drugs threatens to upend the entire market.

An $850M deal for an Arizona cobalt plant marks a pivotal US-Japan move to secure supply chains for defense, EVs, and advanced tech from rivals.

Schulich School of Business and CGI partner on an AI-powered certificate to address critical tech talent shortages and create new career pathways.

ThreatDown, the business-focused unit from Malwarebytes, has radically transformed its sales model, betting its future on a partner-first strategy.

A new report reveals 80% of security pros fear AI will cut jobs, while AI-powered malware and ransomware attacks continue to surge globally.

A new partnership between insurer Chubb and tech firm VCT introduces a proactive approach to prevent trial risks, enhancing patient safety and data integrity.

A shocking survey reveals most Americans believe eye disease has symptoms. A new campaign from Prevent Blindness aims to fight this dangerous misconception.

Ascidian Therapeutics to present first human safety data for its Stargardt disease drug, a new RNA editing technology with broad potential for genetic diseases.

As climate volatility rises, a new platform lets traders build their own forecasts, turning shared weather data into a secret weapon for market advantage.